Related Experiment Videos
Antiarrhythmics in atrial fibrillation
Bethan Freestone1, Gregory Y H Lip
1University Department of Medicine, City Hospital, Birmingham, England, UK.
Current Opinion in Investigational Drugs (London, England : 2000)
|June 11, 2002
Abstract:
Atrial fibrillation (AF) is a common arrhthymia that exists in both the acute and chronic form. As the molecular basis of arrhythmogenesis is further elucidated, the discovery of novel antiarrhythmic agents, which can be tailored to individual patients and the particular subtype of AF, while minimizing potential side effects, will become possible.